Developer docs
API playgroundTry for free, no card

Search company profiles

Synthesis Srl

Full company profile

uuid005evpz

Namestring
Synthesis Srl
Company typeenum
Private
Founded yearstring
-
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
Markets served

Serves global market

Keyword5 values
Italian limited liability company, Milan-based business, small enterprise services, corporate service provider, business services Italy
Industry4 codes
PRIMARYHLAGAHAG
Impurity / Reference Standard Synthesis & Characterization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAHAL
GMP Scale-Up, Tech Transfer & Process Validation (PPQ)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAHAM
Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAIALAD
CMC & Pharmaceutical Development (Formulation/Process/Analytical Development)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development
NAICS code1 code
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Unknown
Social media profiles1 record
Cost components1 value
Personnel
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

No description of core offerings is available in the source content. The only verifiable facts about Synthesis Srl are its Italian Srl legal form, 2020 founding date, 23-employee headcount, and Milan-based headquarters. The company's website returned only a security verification/loading page.

Differentiator
Functional benefit
Problem solved
No data
Peers10 records
TypeDirect peer
Description

Specialty manufacturer of reference standards, impurities, and research chemicals — directly comparable if Synthesis Srl is positioned in impurity / reference-standard synthesis and characterization.

TypeDirect peer
Description

Italian CDMO focused on small-molecule API development and manufacturing, including custom synthesis and process R&D — a direct competitor for synthesis contracts from European pharma customers.

3Olon S.p.A.
TypeDirect peer
Description

Italian API manufacturer with a strong position in generic and contract small-molecule synthesis, including HPAPI and fermentation. Comparable as a domestic Italian peer in the same chemistry/synthesis services category.

4Recipharm
TypeBroad incumbent
Description

Large European CDMO offering a broad portfolio including small-molecule API synthesis alongside fill-finish and biologics — represents the incumbent competitive backdrop for small Italian synthesis specialists.

TypeDirect peer
Description

Spanish-headquartered pharma group with significant Italian operations (Chemo Italy) covering API synthesis, CDMO and finished dosage forms — comparable scale and service offering for small-molecule synthesis work.

TypeBroad incumbent
Description

Global life-science catalog supplier with an extensive reference-standard and analytical chemicals portfolio — represents the dominant incumbent that any small Italian synthesis entrant must displace or differentiate against.

TypeDirect peer
Description

Italian CDMO headquartered near Vicenza specializing in API synthesis, GMP manufacturing and process development for small molecules — a directly comparable Italian synthesis services operator with similar offerings to the inferred profile of Synthesis Srl.

TypeBroad incumbent
Description

Swiss-listed CDMO with deep capabilities in small-molecule API synthesis and process industrialization. A larger, established counterpart competing for similar European pharma development contracts.

TypeBroad incumbent
Description

Major global supplier of reference standards, CRMs and impurity standards used by pharma QC labs — directly relevant competitor if Synthesis Srl serves the impurity / reference-standard niche.

TypeBroad incumbent
Description

Eurofins network offers contract analytical and small-molecule synthesis/CMC services across Europe; a large incumbent competitor relevant to Synthesis Srl's likely service offering.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses3 records

Each record includes

Headline, Details, Source

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights3 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

No data
Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Synthesis Srl

Synthesis Srl firmographics

Firmographics
Name
Synthesis Srl
Website
https://synthesis-srl.it
Company type
Private
Headcount range
11–50 employees
Ownership category
akta.pro rank

Synthesis Srl industry classification

Industry
Product category
Unknown
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAHAG
Impurity / Reference Standard Synthesis & Characterization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAHAL
GMP Scale-Up, Tech Transfer & Process Validation (PPQ)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAHAM
Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAIALAD
CMC & Pharmaceutical Development (Formulation/Process/Analytical Development)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development

Keywords

  • Italian limited liability company
  • Milan-based business
  • Small enterprise services
  • Corporate service provider
  • Business services Italy

Synthesis Srl business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel

Synthesis Srl product offering

Product offering

Core offering

No description of core offerings is available in the source content. The only verifiable facts about Synthesis Srl are its Italian Srl legal form, 2020 founding date, 23-employee headcount, and Milan-based headquarters. The company's website returned only a security verification/loading page.

Differentiator

Problem solved

Functional benefit

Synthesis Srl technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Synthesis Srl competitors and assessment

Company assessment

Direct peers

  • Toronto Research Chemicals: Specialty manufacturer of reference standards, impurities, and research chemicals — directly comparable if Synthesis Srl is positioned in impurity / reference-standard synthesis and characterization.
  • Procos S.p.A. Italian CDMO focused on small-molecule API development and manufacturing, including custom synthesis and process R&D — a direct competitor for synthesis contracts from European pharma customers.
  • Olon S.p.A. Italian API manufacturer with a strong position in generic and contract small-molecule synthesis, including HPAPI and fermentation. Comparable as a domestic Italian peer in the same chemistry/synthesis services category.
  • Chemo S.A. (Insud Pharma): Spanish-headquartered pharma group with significant Italian operations (Chemo Italy) covering API synthesis, CDMO and finished dosage forms — comparable scale and service offering for small-molecule synthesis work.
  • Fabbrica Italiana Sintetici (FIS): Italian CDMO headquartered near Vicenza specializing in API synthesis, GMP manufacturing and process development for small molecules — a directly comparable Italian synthesis services operator with similar offerings to the inferred profile of Synthesis Srl.

Broad incumbents

  • Recipharm: Large European CDMO offering a broad portfolio including small-molecule API synthesis alongside fill-finish and biologics — represents the incumbent competitive backdrop for small Italian synthesis specialists.
  • Sigma-Aldrich (Merck KGaA): Global life-science catalog supplier with an extensive reference-standard and analytical chemicals portfolio — represents the dominant incumbent that any small Italian synthesis entrant must displace or differentiate against.
  • Siegfried Holding AG: Swiss-listed CDMO with deep capabilities in small-molecule API synthesis and process industrialization. A larger, established counterpart competing for similar European pharma development contracts.
  • LGC Standards: Major global supplier of reference standards, CRMs and impurity standards used by pharma QC labs — directly relevant competitor if Synthesis Srl serves the impurity / reference-standard niche.
  • Eurofins CDMO: Eurofins network offers contract analytical and small-molecule synthesis/CMC services across Europe; a large incumbent competitor relevant to Synthesis Srl's likely service offering.

Market position

Strengths3 records

Weaknesses3 records

Key risks4 records

Key highlights3 records

Customer concentration

Synthesis Srl social profiles

Digital presence

Synthesis Srl financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Synthesis Srl leadership team

Management profile

Number of profiles

Synthesis Srl funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Synthesis Srl M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Synthesis Srl

What does Synthesis Srl do?

No description of core offerings is available in the source content. The only verifiable facts about Synthesis Srl are its Italian Srl legal form, 2020 founding date, 23-employee headcount, and Milan-based headquarters. The company's website returned only a security verification/loading page.

When was Synthesis Srl founded?

Synthesis Srl was founded in -1. It employs 11 to 50 people.

Who are Synthesis Srl's main competitors?

Direct peers on record are Toronto Research Chemicals, Procos S.p.A., Olon S.p.A., Chemo S.A. (Insud Pharma) and Fabbrica Italiana Sintetici (FIS). Broad incumbents are Recipharm, Sigma-Aldrich (Merck KGaA), Siegfried Holding AG, LGC Standards and Eurofins CDMO.

Does Synthesis Srl have an API?

No public API is recorded for Synthesis Srl.

What industry is Synthesis Srl in?

Synthesis Srl's product category is Unknown. Its primary akta.pro industry code is HLAGAHAG, Impurity / Reference Standard Synthesis & Characterization, with a secondary code of HLAGAHAL, GMP Scale-Up, Tech Transfer & Process Validation (PPQ). Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales